Mehmet Akif Topçuoğlu1, Şerefnur Öztürk2

1Hacettepe University Faculty of Medicine, Department of Neurology, Neurology Intensive Care Unit, Ankara, Turkey
2Selcuk University Faculty of Medicine, Department of Neurology, Neurointensive Care Unit, Konya, Turkey

Keywords: SARS-CoV-2, COVID-19, brain, cerebral, neurological, neuromuscular

Abstract

Coronavirus disease-2019 (COVID-19) can be associated with wide-range neurologic symptoms and complications. Parainfectious manifestations that are seen during the active infection period include stroke, olfactory and taste disturbance, encephalopathy, encephalitis, neuropathies, and myopathies. The main postinfectious complications are acute disseminated encephalomyelitis, transverse myelitis, Guillain-Barré syndrome, cognitive disorders, and sleep disorders. COVID-19 commonly causes neurological mid-to-long-term disability. The disease prognosis can be improved with sufficient knowledge, prompt recognition, and effective management of neurological complications.